157 related articles for article (PubMed ID: 18087843)
1. Management of recurrent colorectal cancer with positron emission tomography.
Haji A
Br J Hosp Med (Lond); 2007 Nov; 68(11):580-3. PubMed ID: 18087843
[TBL] [Abstract][Full Text] [Related]
2. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Watson AJ; Lolohea S; Robertson GM; Frizelle FA
Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
[TBL] [Abstract][Full Text] [Related]
3. Established, emerging and future roles of PET/CT in the management of colorectal cancer.
Herbertson RA; Scarsbrook AF; Lee ST; Tebbutt N; Scott AM
Clin Radiol; 2009 Mar; 64(3):225-37. PubMed ID: 19185652
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
5. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer.
Arulampalam T; Costa D; Visvikis D; Boulos P; Taylor I; Ell P
Eur J Nucl Med; 2001 Dec; 28(12):1758-65. PubMed ID: 11734912
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography in colorectal cancer.
Flamen P
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):237-51. PubMed ID: 11969236
[TBL] [Abstract][Full Text] [Related]
7. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
Pelosi E; Deandreis D
Eur J Surg Oncol; 2007 Feb; 33(1):1-6. PubMed ID: 17126522
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
[TBL] [Abstract][Full Text] [Related]
9. A new imaging technique for colorectal cancer: positron emission tomography.
Flamen P; Van Cutsem E; Mortelmans L
Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
[No Abstract] [Full Text] [Related]
10. Gastrointestinal tract malignancies and positron emission tomography: an overview.
Esteves FP; Schuster DM; Halkar RK
Semin Nucl Med; 2006 Apr; 36(2):169-81. PubMed ID: 16517238
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer.
Lonneux M; Reffad AM; Detry R; Kartheuser A; Gigot JF; Pauwels S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):915-21. PubMed ID: 12111132
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography and colorectal cancer.
Arulampalam TH; Costa DC; Loizidou M; Visvikis D; Ell PJ; Taylor I
Br J Surg; 2001 Feb; 88(2):176-89. PubMed ID: 11167864
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
[TBL] [Abstract][Full Text] [Related]
14. Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
Francis DL; Visvikis D; Costa DC; Croasdale I; Arulampalam TH; Luthra SK; Taylor I; Ell PJ
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):928. PubMed ID: 15034675
[No Abstract] [Full Text] [Related]
15. Positron emission tomography and colorectal carcinoma: an update.
Tzimas GN; Koumanis DJ; Meterissian S
J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
[No Abstract] [Full Text] [Related]
16. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer.
Kim JH; Czernin J; Allen-Auerbach MS; Halpern BS; Fueger BJ; Hecht JR; Ratib O; Phelps ME; Weber WA
J Nucl Med; 2005 Apr; 46(4):587-95. PubMed ID: 15809480
[TBL] [Abstract][Full Text] [Related]
17. The role of positron emission tomography in the management of colorectal cancer.
Tutt AN; Plunkett TA; Barrington SF; Leslie MD
Colorectal Dis; 2004 Jan; 6(1):2-9. PubMed ID: 14692944
[TBL] [Abstract][Full Text] [Related]
18. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Liu FY; Chen JS; Changchien CR; Yeh CY; Liu SH; Ho KC; Yen TC
Dis Colon Rectum; 2005 Oct; 48(10):1900-12. PubMed ID: 15991059
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.
Chessin DB; Kiran RP; Akhurst T; Guillem JG
J Am Coll Surg; 2005 Dec; 201(6):948-56. PubMed ID: 16310700
[No Abstract] [Full Text] [Related]
20. Recent evidences of the use of 18F-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer.
Dias AR; Nahas SC; Camargo EE; Nahas CS
J Surg Educ; 2007; 64(2):114-9. PubMed ID: 17462214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
